ET
AHCO icon

Entropy Technologies’s AdaptHealth AHCO Stock Holding History

Entropy Technologies’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-13,906
Closed -$160K – 655
2024
Q1 		$160K Sell
13,906
-13,679
-50% -$116K 0.02% 668
2023
Q4 		$201K Buy
+27,585
New +$217K 0.04% 514

Other funds holding AHCO

OCA
OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return

Entropy Technologies's AHCO Position: Q2 2024 in Review

Entropy Technologies sold out of AdaptHealth (AHCO) in Q2 2024, closing a stake of 13,906 shares — an estimated $160K sold.

Entropy Technologies first reported a position in AHCO in Q4 2023 and held it in 2 quarters. The position peaked at $201K in Q4 2023. 207 funds tracked by Wall St. Rank hold AHCO as of Q2 2024.

  • Entropy Technologies reported no remaining AdaptHealth position as of Q2 2024 after selling out during the quarter.
  • Entropy Technologies sold 13,906 AdaptHealth shares in Q2 2024, an estimated $160K.
  • Entropy Technologies first reported a position in AdaptHealth in Q4 2023 and held it in 2 quarters.
  • Entropy Technologies's AdaptHealth position peaked at $201K in Q4 2023.
  • 207 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2024.

Based on Entropy Technologies's 13F filing for Q2 2024, filed 12 Aug 2024.